Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Dobson, T. Chester, J. Drew, P. Keeling (Torquay, United Kingdom). Beta blockers in heart failure and airways disease. Eur Respir J 2010; 36: Suppl. 54, 2490

Member's Comments

No comment yet.

Related content which might interest you: Beta blocker prescription in patients with coexisting cardiac and obstructive airways disease Source: Eur Respir J 2004; 24: Suppl. 48, 278s Year: 2004 Long-term monitoring of respiratory function and influence of selective beta blockers on its decline in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2001; 18: Suppl. 33, 25s Year: 2001 Impact of beta-blockers on sleep-disoredered breathing in chronic heart failure Source: Eur Respir J 2007; 30: Suppl. 51, 509s Year: 2007 Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Pulmonary hypertension associated with left heart disease Source: Eur Respir Mon 2012; 57: 119-137 Year: 2012 COPD in heart failure patients Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial Source: Eur Respir J 2006; 27: 972-979 Year: 2006 Alterations in cardiovascular function in COPD and heart failure patients with sarcopenia Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases Year: 2020 Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure Source: Eur Respir J 2011; 37: 578-586 Year: 2011 Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension Source: Eur Respir J 2011; 38: 359-367 Year: 2011 Elevation of cardiac enzymes in COPD patients with respiratory failures Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Evaluation of pulmonary functions in valvular heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002 Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure Source: International Congress 2019 – More and more COPD Year: 2019 Right heart failure in pulmonary hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Acute effects of different levels of continuous positive airway pressure on cardiac autonomic modulation in chronic heart failure and chronic obstructive pulmonary disease Source: Annual Congress 2010 - Physiotherapeutic evaluation and treatment in the acute setting Year: 2010 Autonomic dysfunction, cardio-pulmonary parameters and masked heart failure in non-severe chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Respiratory diseases, hypoxia and cardiovascular function Year: 2020 Heart arrhythmias in patients with chronic obstructive bronchitis and ischemic heart disease Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004 Effects of Diltiazem on pulmonary hemodynamics and right heart function in patients with chronic obstructive pulmonary disease (COPD)> Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 OSA as a cause of cardiovascular disease, including heart failure Source: ERS Conference Year: 2015